Society endorses position statement on growth hormone delivery device choice

04 Apr 2018


The Society has endorsed a British Society for Paediatric Endocrinology and Diabetes (BSPED) position statement on the choice of device for growth hormone delivery.

The statement is in accordance with NICE guidance and recommends that the choice of delivery method should be assessed on an individual basis.

Read the full statement


Share this story